News | September 27, 2024
Zydus and CSIR-CDRI Lucknow to develop drug for CKD induced Osteoporosis
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Boehringer Ingelheim aims to develop this program as a potential key centerpiece component for its immuno-oncology portfolio
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Merck shared updates on the company’s oncology pipeline and focused R&D approach
225Ac-PSMA-Trillium is an investigational next-generation PSMA-targeted alpha therapy with potential to treat patients with advanced metastatic prostate cancer
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Aurigene.AI is an end-to-end solution for small molecule drug discovery
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Additional capacity broadens Grace’s fine chemical capabilities for API production
BHL will undertake the development and supply of these molecules
Subscribe To Our Newsletter & Stay Updated
